Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Setmelanotide

Open-Label Extension Study of Setmelanotide

Rhythm · Phase 3 · Completed · Enrollment 28

NCT06596135

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Setelanotide (Open-label)n/rn/rn/rn/r

Not shown

  • Setelanotide (Open-label): endpoint not reported